GSK vs SGBX · P/E 13, $103.31B cap vs rev $5.0M
GlaxoSmithKline PLC ADR (GSK) versus SG Blocks Inc (SGBX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
SG Blocks Inc (SGBX) is a metal fabrication company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SGBX revenue for 2024-12-31 was $5.0M. Net income was -$17.0M. Revenue was down 69.9% from 2023-12-31 to 2024-12-31. SGBX currently screens at market cap $9.3M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SGBX currently screens at market cap $9.3M.
Not investment advice. Open the GSK and SGBX stock pages for the full models.
Not investment advice.